You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Takeda Pharmaceuticals U.S.A., Inc. v. Granules Pharmaceuticals Inc. (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Takeda Pharmaceuticals U.S.A., Inc. v. Granules Pharmaceuticals Inc. (D. Del. 2017)

Docket	⤷ Sign Up	Date Filed	2017-07-25
Court	District Court, D. Delaware	Date Terminated	2017-12-28
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,296; 8,093,297; 8,093,298; 8,097,655; 8,415,395; 8,415,396; 8,440,721; 8,440,722
Link to Docket	External link to docket

Small Molecule Drugs cited in Takeda Pharmaceuticals U.S.A., Inc. v. Granules Pharmaceuticals Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Takeda Pharmaceuticals U.S.A., Inc. v. Granules Pharmaceuticals Inc. (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-01-01	19		8,093,298; 7,964,648; 8,093,297; US 7,619,004; US 7,601,758; US 7,820,681; US 7,915,269; US 7,964,647; US … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731… 28 December 2017 1:17-cv-01019 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2017-07-25	3		Notice: June 23, 2017. Date of Expiration of Patent: 7,619,004 expires 12/3/2028.Thirty Month Stay Deadline… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 28 December 2017 1:17-cv-01019 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.